Brief: Shinil Pharmaceutical receives patent

Sinil Pharmaceutical

18/08/2017 02:51

Aug 18 (Reuters) - Sinil Pharmaceutical Co Ltd  012790.KQ  : 
     
    * Says it received patent on Aug. 17, for fragment antigen 
binding specifically binding to epidermal growth factor receptor 
    * Patent number is 10-2015-0126894 
     
     
    Source text in Korean: https://goo.gl/suXxyL 
    Further company coverage:  012790.KQ  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))